Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2024 Jul 1;35(5):232-237.
doi: 10.1097/MBC.0000000000001305. Epub 2024 Apr 26.

Bleeding risk in hemophilia A and B carriers: comparison of factor levels determined using chronometric and chromogenic assays

Affiliations
Comparative Study

Bleeding risk in hemophilia A and B carriers: comparison of factor levels determined using chronometric and chromogenic assays

Delphine Chiffré-Rakotoarivony et al. Blood Coagul Fibrinolysis. .

Abstract

Background: Predicting the bleeding risk in hemophilia A and B carriers (HAC, HBC) is challenging.

Objective: The objectives of this study were to describe the bleeding phenotype in HAC and HBC using the standardized Tosetto bleeding score (BS); to determine whether the BS correlates better with factor levels measured with a chromogenic assay than with factor levels measured with chronometric and thrombin generation assays; and to compare the results in HAC and HBC.

Methods: This ambispective, noninterventional study included obligate and sporadic HAC and HBC followed at a hemophilia treatment center between 1995 and 2019.

Results and conclusion: The median BS (3, range 0-21 vs. 3.5, range 0-15, P = ns, respectively) and the abnormal BS rate (35.6% vs. 38.2%, P = ns) were not significantly different in 104 HAC and 34 HBC (mean age: 38 years, 6-80 years). However, some differences were identified. The risk of factor deficiency was higher in HBC than HAC. Specifically, Factor VIII activity (FVIII):C/Factor IX activity (FIX):C level was low (<40 IU/dl) in 18.3% (chronometric assay) and 17.5% (chromogenic assay) of HAC and in 47% and 72.2% of HBC ( P < 0.001). Moreover, the FIX:C level thresholds of 39.5 IU/dl (chronometric assay) and of 33.5 IU/dl (chromogenic assay) were associated with very good sensitivity (92% and 100%, respectively) and specificity (80% for both) for bleeding risk prediction in HBC. Conversely, no FVIII:C level threshold could be identified for HAC, probably due to FVIII:C level variations throughout life.

PubMed Disclaimer

References

    1. Hermans C, Kulkarni R. Women with bleeding disorders. Haemophilia 2018; 24:29–36.
    1. Van Galen KPM, d’Oiron R, James P, Abdul-Kadir R, Kouides PA, Kulkarni R, et al. A new hemophilia carrier nomenclature to define hemophilia in women and girls: Communication from the SSC of the ISTH. J Thromb Haemost 2021; 19:1883–1887.
    1. Plug I, Mauser-Bunschoten EP, Bröcker-Vriends AHJT, Ploos Van Amstel HK, Van Der Bom JG, Van Diemen-Homan JEM, et al. Bleeding in carriers of haemophilia. Blood 2006; 108:52–56.
    1. Labarque V, Perinparajah V, Bouskill V, Stain AM, Wakefield C, Manuel C, et al. Utility of factor VIII and factor VIII to von Willebrand factor ratio in identifying 277 unselected carriers of hemophilia A. Am J Hematol 2017; 92:E94–E96.
    1. Di Michele DM, Gibb C, Lefkowitz JM, Ni Q, Gerber LM, Ganguly A. Severe and moderate haemophilia A and B in US females. Haemophilia 2014; 20:e136–e143.

Publication types

MeSH terms